Primary Biliary Cholangitis Trial, Recruiting NCT06864195 Sponsor: Imperial College London Condition: Primary Biliary Cholangitis
Back to Primary Biliary Cholangitis

Primary Biliary Cholangitis Trial, Recruiting

NCT06864195
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Men and women aged 18 or older
  • People who have been diagnosed with liver cancer (hepatocellular carcinoma or cholangiocarcinoma), confirmed by tissue sample or scan
  • People who have liver cirrhosis (scarring of the liver), confirmed by scan or tissue sample
  • People who have primary sclerosing cholangitis (a condition affecting the bile ducts), confirmed by a specialist scan or tissue sample
  • People who have general digestive or stomach symptoms but whose liver appears normal on a scan (to act as a comparison group)

Who may not be able to join:

  • People who have had an active infection, or who have been taking medication that suppresses the immune system, within the last eight weeks
  • People who have had a different type of cancer within the last five years
  • People who have previously had surgery to remove part of their liver
  • People who have already started chemotherapy, radiotherapy, or surgery for their liver cancer
  • People whose other health conditions would prevent them from providing a breath sample (confirm with trial site)
  • Women who are pregnant (this will be checked verbally during the process)
  • People who are unable to read, understand, and sign a consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: George Hanna, Imperial College London

Phone: +02075943396

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
13 February 2025
Est. completion
31 January 2027

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Diagnostic Accuracy of VOC Analysis for Liver Cancer Detection

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov